Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: The DETECT Study: Discovery and Evaluation of Testing for Endometrial and Ovarian Cancer in Tampons
The DETECT study is evaluating tampon-based testing for detection of endometrial cancer, endometrial cancer precursors, and ovarian cancer; …
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: OCS Products Based on Exosome Technology Were Applied in the Recurrence Monitoring Study After the Initial Treatment of Baseline CA125-negative Ovarian Cancer
The document reports a clinical trial update where exosome-based OCS products are being used for recurrence monitoring after initial treatme…
-
CLINICAL_TRIALS research · 2025-08-28Clinical Trial Update: Etoposide Capsules Combined With Bevacizumab and Iparomlimab and Tuvonralimab in the Treatment of Platinum Resistant or Platinum Refractory Ovarian Cancer [Phase 2]
Phase 2 clinical trial update examining etoposide capsules plus bevacizumab, iparomlimab, and tuvonralimab for platinum-resistant or platinu…
-
CLINICAL_TRIALS research · 2025-08-28Clinical Trial Update: Investigation of the Anti-tumor Effect of 2X-121 in Patients With Recurrent, Advanced Ovarian Cancer [Phase 2]
An ongoing Phase 2 trial evaluating the anti-tumor effects of 2X-121 in patients with recurrent, advanced ovarian cancer. Recruitment is ong…
-
CLINICAL_TRIALS research · 2025-08-27Clinical Trial Update: Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers [Phase 2]
Phase 2 clinical trial update evaluating cryocompression with or without cilostazol to prevent paclitaxel-induced neuropathy in gynecologic …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-08-27Clinical Trial Update: Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating Gavo-cel (TC-210), a mesothelin-targeted therapy, in patients with advanced mesothelin-expressing cancer…
-
CLINICAL_TRIALS research · 2025-08-27Clinical Trial Update: A Study to Explore Personalized Treatment for Patients With Recurrent Gynecological Malignancies Based on MTB
Sun Yat-sen University is recruiting a study to explore personalized treatment for patients with recurrent gynecologic cancers guided by MTB…
-
CLINICAL_TRIALS research · 2025-08-21Clinical Trial Update: Regorafenib Combined With Fulvestrant in Recurrent Low-Grade Serous Ovarian Cancer [Phase 2]
This Phase 2 clinical trial evaluates regorafenib in combination with fulvestrant for recurrent low-grade serous ovarian cancer and is curre…
-
CLINICAL_TRIALS research · 2025-08-17Clinical Trial Update: Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 clinical trial update on cabozantinib alone or with atezolizumab for locally advanced or metastatic solid tumors; the study lists mu…
-
CLINICAL_TRIALS research · 2025-08-15Clinical Trial Update: A Study of IBI363 Combination Therapy in Participants With Advanced Solid Tumors [Phase 2]
A Phase 2 study of IBI363 in combination therapy for advanced solid tumors, including EGFR-mutant non-small cell lung cancer and platinum-re…
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: Combination Therapy of Senaparib and Bevacizumab for First-line Maintenance Therapy in Newly Diagnosed Advanced Homologous Recombination Proficient Ovarian Cancer Based on Exosome Protein Marker [Phase 2]
Phase 2 clinical trial evaluating the combination of senaparib and bevacizumab as first-line maintenance therapy for newly diagnosed advance…
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues [EARLY_Phase 1]
An early-phase 1 trial is investigating experimental PET imaging scans performed before cancer surgery to assess tracer uptake in normal and…
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: Exploring the Potential of Novel Biomarkers Based on Plasma microRNAs for a Better Management of Pelvic Gynecologic Tumors [NA]
This clinical trial update discusses exploring plasma microRNA biomarkers to improve management of pelvic gynecologic tumors, focusing on ov…
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: Proactive Hemodynamic Management During Cytoreductive Surgery and HIPEC [NA]
This ClinicalTrials.gov entry describes a study on proactive hemodynamic management during cytoreductive surgery with HIPEC for ovarian canc…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer [Phase 1]
Nuvectis Pharma's NXP800 is being studied in a Phase 1 trial for advanced solid tumors with expansion into ovarian cancer, and the study is …
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: Constitution of ex Vivo Ovarian Tumor Models for the Validation of the Interest of Innovative Therapies and the Search for Tumor or Circulating Biomarkers Predictive of Treatment Response
The document reports a completed clinical trial focused on creating ex vivo ovarian tumor models to validate innovative therapies and identi…
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: Clinical Study on the Re-irradiation of Lateral Pelvic Recurrences of Gynecological Malignancies [NA]
A ClinicalTrials.gov study evaluating re-irradiation for lateral pelvic recurrences in gynecologic cancers; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 trial update for TRK-950 in combination with anti-cancer regimens in patients with advanced solid tumors; the study is active but no…
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: Clinical Significance of Germline BRCA Mutations
This clinical trial update discusses the clinical significance of germline BRCA mutations in patients with breast cancer and ovarian cancer.…
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: Anatomopathological Analysis of the Infundibulopelvic Ligament in Patients With Ovarian Cancer
This clinical trial update outlines a study evaluating anatomopathological analysis of the infundibulopelvic ligament in patients with ovari…
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: Expanded Access Use of DKN-01 for the Treatment of Advanced Solid Tumors
Expanded-access update for Leap Therapeutics' DKN-01 in advanced solid tumors, noting the program is no longer available and targeting multi…
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer [Phase 2]
A Phase 2 clinical trial is evaluating Abemaciclib for recurrent gynecologic cancers, including endometrial, fallopian tube, ovarian, and pr…
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: Study of SYN608 for the Treatment of Advanced or Metastatic Solid Tumors [Phase 1]
An early-phase (Phase 1) study of SYN608 for advanced or metastatic solid tumors is not yet recruiting. The indications include ovarian canc…
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: A Study of DS-6000a in Subjects With Advanced Renal Cell Carcinoma and Ovarian Tumors [Phase 1]
Phase 1 study evaluating DS-6000a in adults with advanced renal cell carcinoma and ovarian cancer; the trial is currently active but not rec…
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: ETC-159 In Combination With Pembrolizumab In Advanced MSS/pMMR Ovarian Cancers [Phase 1]
This update describes a Phase 1 trial evaluating ETC-159 in combination with pembrolizumab for advanced MSS/pMMR platinum-resistant ovarian …